Investigators conducted this phase III trial to determine whether immunotherapy was more effective when administered early in the day.

Comparative Study of Chemotherapy Tolerance and Immune Function Changes in Gynecological Malignancy Patients with HIV ...

Northwestern Medicine scientists in the laboratory of Stephen Miller, Ph.D., professor emeritus of Microbiology–Immunology, have identified the cellular and molecular mechanisms required for the ...

When the heart’s muscle is weakened or injured due to a heart attack, it can make it hard for the heart to pump enough blood ...

India is home to the third-largest population of people living with HIV/AIDS, with women accounting for a significant portion ...

Discover the latest findings on cancer immunotherapy and the role of TET2 gene in immune response for better treatment ...

In women with HIV infection, antiretroviral therapy containing tenofovir disoproxil fumarate does not have a clinically ...

CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced ...

People who commonly experience everyday discrimination are more likely to have higher levels of "exhausted" white blood cells ...